Searched for
STRIDES PHARMA
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...- Quant Small Cap Fund exits HDFC Bank, Jio Financial Services and 5 other stocks in AprilQuant Small Cap Fund reshuffled its portfolio in April, exiting seven stocks including HDFC Bank and Jio Financial Services while adding ne...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa businessStrides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...
- Strides Pharma Q3 Results: PAT rises over 2-fold at Rs 208.12 croreStrides Pharma Science Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 208.12 crore in the third quarter ended D...
- Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs...
- Strides Pharma Q4 Results: Pharma co reports Rs 10.4 crore net profitStrides Pharma Science posted a net profit of Rs 10.4 crore in Q4FY24, rebounding from a loss of Rs 1 crore in the same period last year. P...
- Buy Strides Pharma Science, target price Rs 630: Prabhudas LilladherPromoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
- Reduce Strides Pharma Science, target price Rs 495: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4766.18 Crore) operating in Pha...
- Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...
- Strides Pharma announces business rejig. Shares end 7% up, hit 52 week highThe announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's...
- Strides Pharma to spin off contract development unitStrides Pharma Science on Monday said it would spin off its contract development and manufacturing organisation (CDMO) and soft gelatin bus...
- Buy Strides Pharma Science, target price Rs 500: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3085.64 Crore) operating in Pha...
- Buy Strides Pharma Science, target price Rs 402: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3026.83 Crore) operating in Pha...
- Stride Pharma Science Q1 Results: Net loss narrows to Rs 163 croreRevenue from the US business in the June quarter stood at Rs 355.2 crore, up from Rs 301.6 crore last year.Similarly, the company said its ...
- Accumulate Strides Pharma Science, target price Rs 355: GeojitStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2836.92 Crore) operating in Pha...
- Strides Pharma Science arm gets American drug regulator's nod for pain relieving drugStrides Pharma Global Pte. Limited, Singapore, has received approval for Ibuprofen Oral Suspension USP, 100 mg/5 mL from the United States ...
- Strides Pharma Q3 results: Net profit declines 62% to Rs 35 crThe company had posted a net profit of Rs 92.33 crore for the corresponding period of the previous fiscal, Strides Pharma Science said in a...
- Strides Pharma gets tentative nod from USFDA for pain relieving drugStrides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United ...
- Strides Pharma arm signs pacts for sale of Australian business to Arrow PharmaThe company said it expects the transaction to close on or around July 10, 2019.
Load More
